Focal Area Structural Biology and Biophysics, Biozentrum, University of Basel, Basel, Switzerland.
Paul Scherrer Institute, Villigen PSI, Switzerland.
Methods Cell Biol. 2022;169:115-141. doi: 10.1016/bs.mcb.2022.03.001. Epub 2022 Apr 15.
The numerous chemokines and their cognate G protein-coupled chemokine receptors on the surface of leukocytes form a complex signaling network, which regulates the immune response and also other key physiological processes. Currently only a very limited number of structures of chemokine•chemokine receptor complexes have been solved. More structures are needed for the understanding of their mechanism of action and the rational design of drugs against these highly relevant therapeutic targets. Recently, we have determined the cryo-EM structure of the human wild-type CCR5 chemokine receptor, which is also the HIV-1 coreceptor, in its active conformation bound to the chemokine super-agonist [6P4]CCL5 and the heterotrimeric G protein. The structure provides the rationale for the sequence-activity relation of agonist and antagonist CCR5 chemokine ligands. In this chapter, we present a detailed protocol for the preparation of the active agonist chemokine•CCR5•G complex for cryo-EM studies including quality controls and caveats. As such the protocol may serve as starting point for structural and biophysical studies of other chemokine•chemokine receptor complexes.
白细胞表面大量的趋化因子及其同源的 G 蛋白偶联趋化因子受体构成了一个复杂的信号网络,调节免疫反应和其他关键的生理过程。目前,仅解决了非常有限数量的趋化因子-趋化因子受体复合物的结构。为了理解它们的作用机制和针对这些高度相关的治疗靶点的药物的合理设计,需要更多的结构。最近,我们已经确定了人类野生型 CCR5 趋化因子受体的冷冻电镜结构,该受体也是 HIV-1 的核心受体,处于与其结合的活性构象[6P4]CCL5 和异三聚体 G 蛋白。该结构为激动剂和拮抗剂 CCR5 趋化因子配体的序列-活性关系提供了依据。在本章中,我们提供了一个详细的方案,用于制备用于冷冻电镜研究的活性激动剂趋化因子-CCR5-G 复合物,包括质量控制和注意事项。因此,该方案可以作为其他趋化因子-趋化因子受体复合物的结构和生物物理研究的起点。